Background: Exposure of the developing brain to propofol results in cognitive deficits. Recent data suggest that inhibition of neuronal apoptosis does not prevent cognitive defects, suggesting mechanisms other than neuronal apoptosis play a role in anaesthetic neurotoxicity. Proper neuronal growth during development is dependent upon growth cone morphology and axonal transport. Propofol modulates actin dynamics in developing neurones, causes RhoA-dependent depolymerisation of actin, and reduces dendritic spines and synapses. We hypothesised that RhoA inhibition prevents synaptic loss and subsequent cognitive deficits. The present study tested whether RhoA inhibition with the botulinum toxin C3 (TAT-C3) prevents propofol-induced synapse and neurite loss, and preserves cognitive function. Methods: RhoA activation, growth cone morphology, and axonal transport were measured in neonatal rat neurones (5e7 days in vitro) exposed to propofol. Synapse counts (electron microscopy), dendritic arborisation (GolgieCox), and network connectivity were measured in mice (age 28 days) previously exposed to propofol at postnatal day 5e7. Memory was assessed in adult mice (age 3 months) previously exposed to propofol at postnatal day 5e7. Results: Propofol increased RhoA activation, collapsed growth cones, and impaired retrograde axonal transport of quantum dot-labelled brain-derived neurotrophic factor, all of which were prevented with TAT-C3. Adult mice previously treated with propofol had decreased numbers of total hippocampal synapses and presynaptic vesicles, reduced hippocampal dendritic arborisation, and infrapyramidal mossy fibres. These mice also exhibited decreased hippocampal-
factors other than apoptosis also contribute to anaesthetic neurotoxicity and anaesthetic-induced cognitive dysfunction.
Cognitive capacity is contingent upon proper neuronal network development, which depends on proper neuronal migration, synapse formation, and network connectivity during brain development. 22e25 Neurite extension and migration is facilitated by growth cone advancement towards appropriate targets in order to establish functional circuits. 23, 25 This neuronal path finding relies upon actin-dependent events, which include growth cone motility and axonal transport of neurotrophins [i.e. nerve growth factor and brain-derived neurotrophic factor (BDNF)] from nerve terminals back to the cell body and vice versa. 22e25 Disruption of growth cone morphology (via actin dysregulation) or impaired axonal transport leads to aberrant connectivity and impaired cognition. 23,26e30 Actin dynamics are regulated by Rho GTPases (RhoA, Rac1, and Cdc42), small G proteins that activate/deactivate downstream effector proteins. 23, 26, 31 RhoA activation results in actin stress fibre formation, growth cone collapse, and impaired axonal transport; Rac1 and Cdc42 activation facilitates lamellipodia and filopodia formation, growth cone protrusion, and axonal transport. 23, 27, 31 The timing and balance of Rho GTPase activation is critical and necessary for proper neuronal targeting and synapse formation during the critical periods of network formation. 23, 32 Dysfunctional Rho GTPase signalling results in altered actin dynamics and loss of or aberrant neuronal connectivity and cognitive dysfunction. 23, 26, 27, 31, 33, 34 We have shown that anaesthetic exposure of neonatal neurones alters Rho GTPase activity and neurite actin dynamics. 11e13 Given that regulation of actin dynamics plays an important role in neuronal pathfinding, circuit formation, and brain development, 23, 26, 27, 31, 33, 34 and that propofol alters
Rho GTPase signalling, 11e13 we tested the hypothesis that propofol causes neurotoxicity through increased RhoA activation, actin dysregulation, growth cone collapse, impaired axonal transport, and altered neuronal connectivity, all of which lead to cognitive deficits.
Methods

Preparation of neuronal cell cultures
All studies performed on animals were approved by Veteran Affairs San Diego Institutional Animal Care and Use Committee (San Diego, CA, USA) and conform to the guidelines of Public Health Service Policy on Human Care and Use of Laboratory Animals. Embryonic rat neurones (Sprague Dawley; Harlan Laboratories, Inc., Indianapolis, IN, USA) were isolated as described. 35 In brief, hippocampal neurones isolated from rat pups at embryonic age 16e18 were plated on poly-L-lysine coated coverslips in culture plates or within microfluidic chambers (Xona Microfluidics, Temecula, CA, USA). Axons from hippocampal neurones entered the microfluidic chamber microgroove at 3 days in vitro (DIV) and reached the distal axon compartments between 5e7 DIV. During neurone culture maintenance, half the media was removed and replaced with fresh maintenance media every 24e48 h.
Anaesthetic neurotoxicity model in vitro
Primary neuronal cultures (DIV 5e7) were placed in an incubator and exposed to 3 mM propofol (2,6-diisopropylphenol;
Sigma, St Louis, MO, USA) and then placed in an incubator for 2 h in a gas mixture of 5% CO 2 , 21% O 2 , and 74% nitrogen at a flow rate of 2 litres min À1 . Temperature was maintained at 37 C. A subset of neurones was pre-treated with 50 mg ml À1 of the RhoA inhibitor TAT-C3 for 2 h before propofol exposure. To make vehicle control solution, DMSO was diluted to 0.1% in Neurobasal media. Propofol 3uM solution was made by serial dilution in stock DMSO followed by Neurobasal media (final concentration: 3uM propofol in DMSO 0.1%).
Axonal transport of quantum dot-labelled mature BDNF
Neurones (DIV 5e7) were prepared for live imaging of quantum dot (QD)-labelled mature BDNF transport as described. 35 Before live imaging of QD-BDNF transport, microfluidic compartments were depleted of BDNF by rinsing with BDNF-free, serum free Neurobasal® Media (Thermo Fisher Scientific, Waltham, MA, USA) every 30 min for 2 h. Mono-biotinylated brain derived neurotrophic factor was generated as described. 36 QD 655 streptavidin conjugate was purchased from Life Technologies (Life Technologies, San Diego, CA, USA). To prepare the QD-BDNF conjugates, 50 nM monobiotinylated BDNF dimer was mixed with 50 nM QD 655-streptavidin conjugates in Neurobasal® Media and incubated on ice for 1 h. After 1 h incubation, the QD-BDNF was diluted in Neurobasal® Media to a final concentration of 0.25 nM. QD-BDNF (0.25 nM) was added to the distal axonal compartments of the microfluidic chambers for 2 h at 37 C. QD-BDNF is taken up into neurones by TrkB receptor binding and endocytosis. After 2 h incubation with QD-BDNF and before imaging, distal axonal compartments were rinsed three times with Neurobasal® Media to wash off any unbound QD-BDNF. Live QD-BDNF transport was captured with an inverted immunofluorescence microscope system (Leica, Buffalo Grove, IL, USA) using a 100Â oil objective with a Charged coupled device (CCD) camera (Rolero-MGi Fast 1397; Qimaging, Surrey, British Columbia, Canada) and environmental chamber to maintain constant temperature (37 C) and CO 2 (5%). The QD 655 signal was seen using Texas red excitation/emission cubes. Live images of QD-BDNF transport were captured within the middle axons at a camera speed of 1 frame s À1 for 2 min. Kymographs were generated and analysed using MetaMorph Software (Molecular Devices, Sunnyvale, CA, USA). Statistical analysis was performed using Prism 7 (GraphPad Software, La Jolla, CA, USA). Sample size (n) equals the number of QD-BDNF dimers counted per experimental condition.
Protein extraction and immunoblot analysis
Protein lysates were separated by sodium dodecyl sulphateepolyacrylamide gel electrophoresis using 4e12% or 10% acrylamide gels (Invitrogen, Carlsbad, CA, USA) and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA) by electroelution. Membranes were blocked in 20 mM phosphate-buffered saline (PBS)/Tween (1%) containing 3% bovine serum albumin (BSA) and incubated with primary antibody overnight at 4 C. Primary antibodies were seen using secondary antibodies conjugated to horseradish peroxidase (Santa Cruz Biotech, Santa Cruz, CA, USA) and chemiluminescent reagent (Lumigen, Southfield, MI, USA). Image J software (National Institutes of Health, Bethesda, MD, USA) was used for densitometry analysis as described.
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Neurone staining and immunofluorescence microscopy Neurones (DIV 5e7) were prepared for immunofluorescence microscopy as described. 11e13 Primary neurones were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, incubated with 100 mM glycine (pH 7.4) for 10 min to quench aldehyde groups, permeabilised in buffered 0.1% Triton X-100 for 10 min, blocked with 1% BSA/PBS/Tween (0.05%) for 20 min and then incubated with primary antibodies (1:100) in 1% BSA/PBS/Tween (0.05%) for 24e48 h at 4 C. Excess antibody was removed by washing with PBS/Tween (0.1%) for 15 min followed by incubation with Alexa-conjugated secondary antibody (1:250) for 1 h. To remove excess secondary antibody, neurones were washed six times at 5 min intervals with PBS/Tween (0.1%) and incubated for 20 min with the nuclear stain 4 0 ,6-diamidino-2-phenylindole (DAPI) diluted 1:5000 in PBS. RhoA-GTP primary antibody staining (NewEast Biosciences, King of Prussia, PA, USA) normalised to nuclear DAPI staining was utilised to assay RhoA activation. Phalloidin staining was used to assess growth cone area. Neurones were washed for 10 min with PBS and left in PBS for imaging. As described, 37 deconvolution images were captured at 100Â magnification using a DeltaVision deconvolution microscope system (Applied Precision, LLC, Issaquah, WA, USA). This system includes a Photometrics CCD camera mounted on a Nikon TE-200 inverted epifluorescence microscope. Exposure times were set such that the camera response was in the linear range for each fluorophore. Maximal projection volume views or single optical sections were seen. Pixels were assessed quantitatively by CoLocalizer Pro software (Colocalization Research Software, Japan). Neuronal growth cone area was assessed by Aperio ScanScope software (Leica, Buffalo Grove, IL, USA). Differential interference contrast (DIC) images were also captured to assure that any change in phalloidin staining was secondary to growth cone collapse and not a change in the concentration of F-actin alone. Statistical analysis was performed using Prism 6 (GraphPad Software, San Diego, CA, USA).
Anaesthetic neurotoxicity model in vivo
Postnatal day 5e7 (PND 5e7) wild type (WT) male C57BL/6 mice were separated from their dams and placed in a temperaturecontrolled incubator set to 37 C. Animals were randomised into four groups (n¼5 per group). Mice were given a single intraperitoneal (i.p.) injection of propofol or Intralipid (50 mg kg
À1
) followed by two i.p. injections of propofol or Intralipid (25 mg kg
) at 2 h intervals, totalling 6 h of exposure. Before propofol exposure, mice were pre-treated with either TAT-MUT (control) or TAT-C3 (12.5 mg kg À1 , i.p.) for 2 h. Pups were allowed to recover in the incubator for 2 h after the final injection and returned to their dams. Mice were sacrificed 4 weeks after propofol exposure and brains were prepared for further analysis. For behavioural studies, a total of 54 mice were investigated at age 3 months after anaesthetic exposure.
Histological preparation for microscopy
Under deep pentobarbital anaesthesia, a midline thoracotomy was performed on 4-week-old mice, and the descending thoracic aorta was occluded. A 20 gauge needle was inserted into the left ventricle and the animal was perfused transcardially with 20 ml of heparinised saline followed by 20 ml of 4% buffered formalin fixative. 
GolgieCox impregnation
Mice (age 4 weeks) were killed by decapitation after deep 5% isoflurane anaesthesia, and the brain was quickly removed and submerged in GolgieCox solution A þ B (FD Neurotechnologies Inc., Columbia, MD, USA) for 8 days, followed by solution C for 4 days at room temperature and stored at e80 C until processed. Frozen brain tissue was cut coronally on a cryostat at 80-mm-thick sections and stained with solution D þ E and dehydrated according to the manufacturer's instructions. To evaluate hippocampal neurone morphology, a Zeiss AxioImager microscope and a computer-based system (Neurolucida; MBF Bioscience, Williston, VT, USA) were used to generate three-dimensional neurone tracings that were seen and analysed using NeuroExplorer (MBF Bioscience).
Electron microscopy
Mice (age 4 weeks) were transcardially perfused and brain tissue was fixed with standard Karnovsky's fixative, 4% paraformaldehyde, 1% gluteraldehyde, 0.1 M cacodylate buffer with 5 mM CaCl 2 . Hippocampi were dissected from whole brain after 24 h and 400 mm vibratome slices prepared and re-fixed for an additional 24 h. Brains were blocked to include hippocampal areas, one hemisphere for sagittal orientation, and one hemisphere for coronal. Blocks were re-fixed for an additional 24 h followed by post-fixation with 1% OsO 4 in 0.1 M cacodylate buffer, en bloc stained with uranyl acetate and embedded with flat orientation to locate appropriate hippocampal regions of interest. Each block was thick sectioned, stained with toluidine blue, and re-trimmed to isolate hippocampal areas before preparation of grids. Grids (70 nm sections) were stained with uranyl acetate and lead nitrate for contrast and observed on an electron microscope (1200 EX-II; JEOL, Tokyo, Japan) equipped with a digital camera system. Twenty-five random low magnification (2500Â) micrographs and 50 high magnification (15 000Â) micrographs of the CA3 region were obtained from each specimen. Total numbers of synapses and presynaptic vesicles were measured as described. 38 
Behavioural analysis
Fear conditioning was performed on adult mice (age 3 months) exposed to propofol at postnatal day 5e7 as described. 39 In 
Results
Propofol increases RhoA activation, causes growth cone collapse, and impairs retrograde axonal transport of BDNF in primary hippocampal rat neurones
Previous work from our laboratory showed that p75 neurotrophin receptor (p75 NTR ) activation is a contributing factor in propofol-mediated neurotoxicity.
11e13 Because p75 NTR activates RhoA, we hypothesised that propofol exposure of neonatal neurones increases RhoA-GTP (activated RhoA), resulting in growth cone collapse and impaired retrograde axonal transport of BDNF. Neurones (DIV 5e7) grown in microfluidic chambers were exposed to propofol (3 mM, 15 TAT-C3 peptide attenuates propofol-induced growth cone collapse and retrograde axonal transport impairment of BDNF We tested whether inhibition of RhoA activation by TAT-C3 reverses the deleterious effects of propofol. To test this hypothesis, DIV 5e7 neurones grown in microfluidic chambers of quantum dot (QD)-labelled brain-derived neurotrophic factor (BDNF). Neurones were exposed to PPF (3 mM) for (a) 15 min or (b,c) 2 h in 5% CO 2 in air. (a) RhoA activation is indicated by RhoA-GTP immunofluorescence microscopy (green). Actin was stained with phalloidin (red) and nucleus was stained with DAPI (blue). RhoA-GTP is increased in neurones exposed to PPF vs DMSO (control). Quantitation of data is represented in the graph (n¼13e18; *P¼0.03). (b) Growth cone area was evaluated using phalloidin (red). Microtubules were stained for tau protein (green). Microscopy shows a decrease in growth cone area in neurones exposed to PPF vs DMSO (control). Quantitation of the data is represented in the graph (n¼8e10; **P¼0.002). (c) Retrograde axonal transport of BDNF was evaluated by live imaging of QD-BDNF. Representative kymographs are shown for neurones (in vitro days 5e7) exposed to either DMSO (top panel) or PPF (bottom panel). Retrograde movement is left to right. Individual QD-BDNF molecules are seen as a single line on the kymographs. More horizontal sloped lines represent processive movements of QD-BDNF along the axon, while more vertical sloped lines represent stationary, slower, or both QD-BDNF movements along the axon. Live imaging and kymograph analysis show a decrease in net average velocity and decrease in percent retrograde movement of QD-BDNF in neurones exposed to PPF. Quantitation of data is presented in the graphs. Average velocity (n¼51e62; ***P<0.001). Percent movement (n¼51e62; ***P<0.001). DAPI, 4 0 ,6-diamidino-2-phenylindole; DMSO, dimethyl sulfoxide. Data are presented as mean (SEM); P was assumed significant when a < 0.05; *P<0.05, **P<0.01, ***P<0.001.
were pre-treated with TAT-C3 (50 mg ml À1 , 2 h) before propofol exposure. To confirm TAT-C3 inhibition of RhoA activity, we performed a mobility shift assay as described. 40 TAT-C3
(exoenzyme from Clostridium botulinum) inhibits RhoA by ADP ribosylation of asparagine 41 in the effector binding domain of the GTPase, 41 rendering it inactive; this modification increases the molecular weight (i.e. upward shift) of RhoA on immunoblot assay. 40 Lysates of neurones pre-treated with TAT-C3 for 2 h exhibited an upward shift of RhoA molecular weight, with no upward shift in Rac1 molecular weight, confirming the specificity of TAT-C3 inhibition for RhoA (Fig. 2a) . We found a significant effect on relative growth cone area between treatment groups (n¼4, P<0.001) with a significantly smaller growth cone area (phalloidin stain) after propofol exposure (mean rank¼17. showing the lowest % movement compared with DMSO (80%) and TAT-C3 propofol (82%). To look at group to group comparisons in more detail, corrected group to group comparisons Live imaging and kymograph analysis shows a decrease in net average velocity and percent retrograde movement of QD-BDNF in neurones exposed to PPF. Neurones pre-treated with TAT-C3 before PPF exposure show both increased average velocity and percent retrograde movements compared with neurones exposed to PPF. Quantitation of data is presented in the graphs. Average velocity (n¼65e122; ***P<0.001). Percent movement (n¼64e121; ***P<0.001). DMSO, dimethyl sulfoxide; PPF, propofol; C3, TAT-C3; data are presented as mean (Fig. 1b) and impaired retrograde axonal transport of QD-BDNF (Fig. 1c) in vitro, we examined the effect of propofol on mossy fibre bundle formation in PND 5e7 mouse pups in vivo 28 days after propofol exposure. We investigated the mossy fibre bundles of the CA3 region of the hippocampus because its development requires proper axonal pathfinding, which is dependent on growth cone motility and axonal transport. 23,25,45e52 Additionally, synaptic connectivity that constitutes the mossy fibre bundle (dentate gyrus axons synapsing with CA3 dendrites) contributes substantially to learning and memory. 53e58 Synaptoporin antibody was used to stain and assess mossy fibre area within the infrapyramidal mossy fibre (IMF) and suprapyramidal mossy fibre (SMF) bundles. Synaptoporin staining revealed that propofol exposure (indicated as PM in Fig. 3 Fig. 3 ) before propofol exposure ( Fig. 3 : bottom right panel), while there was no effect on the SMF bundles.
Propofol exposure decreases dendritic branching and reduces total synapses in the hippocampus
The number of synapses in the hippocampus is influenced by the degree of dendritic branching. Dendritic branching is in part regulated by balanced Rho GTPases activity, 59e61 and by trophic support from synapsing axon terminals. 62e66 Increased RhoA activation decreases dendritic branching, leading to a decrease in synaptic contacts. 67e70 Because propofol activates RhoA (Fig. 1a) and decreases IMF bundle input toward the CA3 hippocampal region (Fig. 3) , we examined the effects of propofol on dendritic branching and synaptic count in the hippocampus. PND 5e7 mouse pups were exposed to propofol for 6 h and sacrificed 28 days later to assess dendritic branching by Sholl analysis and synaptic count by electron microscopy. 39 For Sholl analysis, the apical dendrites of dentate gyrus granule cells and apical and basal dendrites of CA3 pyramidal neurones within the hippocampus were traced after GolgieCox staining. A representative example of a GolgieCox stained dentate gyrus granule cell is shown (Fig. 4a ) along with neuronal tracings using Neurolucida software (Fig. 4b ) and the corresponding 3D reconstruction with Sholl rings (Fig. 4c ) from one animal. XYZ orientation of the cell in Fig. 4a and the corresponding depths of the cell shown are indicated in Fig. 4d . Fig. 4e shows representative granule cell tracings from each exposure group. Morphological analysis of granule cell apical dendrites demonstrated total number of dendritic intersections and distance from soma were significantly lower after propofol exposure (PM), while pre-treatment with TAT-C3 attenuated propofol-mediated dendritic retraction ( Fig. 4f and g, respectively) . We analysed Fig. 4f Fig. 4h shows representative CA3 pyramidal neurone tracings from each group (IM, IC, PM, PC). Total number of dendritic intersections and distance from soma in the apical dendrites of CA3 pyramidal neurones were significantly lower after propofol exposure (PM; Fig. 4i and j, respectively) and pre-treatment with TAT-C3 significantly attenuated propofol-mediated apical dendritic retraction of CA3 pyramidal neurones (Fig. 4i and j) . We found (Fig. 4i) In contrast, basal dendrites were unaffected by TAT-C3 pre-treatment with no significant difference between groups ( Fig. 4i and j) .
Synaptic count is influenced by Rho GTPase signalling and degree of dendritic branching. 71, 72 Because propofol decreased dendritic branching via RhoA activation in both the dentate gyrus and CA3 granule cell apical dendrites of the hippocampus, we investigated the effect of propofol on synapses using electron microscopy. Synapses and presynaptic vesicles are visible in the representative control images under low magnification (2500Â; Fig. 4k ). Compared with control (Intralipid) exposed mouse pups (IM), propofol (PM) exposure reduced total synapse number ( Fig. 4k and l) . This reduction was attenuated by pre-treatment with TAT-C3 (PC; Fig. 4k Fig. 4m ) showed that propofol (after pre-treated with TAT-MUT) reduced the total number of presynaptic vesicles; TAT-C3 pre-treatment reversed the propofol-mediated reductions in total synapse and presynaptic vesicle numbers ( Fig. 4m and  n Propofol exposure of PND 5e7 mouse pups impairs hippocampus-dependent contextual fear memory 3 months after exposure
Propofol exposure of neonatal mice altered hippocampal architecture in vivo (Figs 3 and 4) : decreased IMF bundle area 
Intralipid þ TAT-MUT vs Intralipid þ TAT-C3. (Fig. 3) ; decreased dendritic arborisation (Fig 4aej) ; decreased total synapse ( Fig. 4k and l) and presynaptic vesicle number ( Fig. 4m and n) . We therefore tested whether propofol exposure of neonatal mice affected hippocampus-dependent learning and memory at age 3 months. Mice were weighed and baseline tested for gross motor function and anxiety in the open field paradigm to exclude any obvious dysfunction before testing learning and memory behaviours ( Supplementary  Fig. S1 ). We exposed PND 5e7 mice to propofol or Intralipid (vehicle control) i.p. injection and then assessed cognitive behaviour using a fear conditioning learning and memory test at 3 months of age. Data during the learning phase on day 1 were analysed with a three-way ANOVA (Fig. 5a) (4)]. On day 3, mice were re-exposed to the cue and showed a significant effect for the factor propofol [F(1,50)¼4.28, P¼0.04] and no significant comparisons between groups. Post hoc power analysis for ANOVA with an effect size f¼0.4, a¼0.05, yielded a total sample size of n¼54 degrees of freedom (dfn)¼1 and four groups as a representative for our fear conditioning analysis ( Fig. 5b and c) . The results yielded a critical F value of 4.03 and 1eb¼0.82. Based on this, with an effect size of 0.4 and our current group size, our study has a statistical power of 82%. These data indicate that propofol/TAT-MUT treated mice had deficits during cued learning (day 1) and context recollection (day 2), a deficit that was prevented by TAT-C3 pre-treatment, while an overall effect of propofol was observed during cue presentation on day 3 (Fig. 5aec) .
Discussion
Propofol exposure of neonatal neurons, both in vitro and in vivo, results in growth cone collapse, impairment in axonal transport of key neurotrophin positive vesicles, retraction of hippocampal mossy fibre networks, altered hippocampal dendritic arborisation, and decreases in total synapse and presynaptic vesicle number, all of which were accompanied by cognitive deficits. These neuropathological changes were prevented by TAT-C3, a small peptide that inhibits RhoA activation, suggesting that RhoA activation plays a critical role in propofol-mediated neurotoxicity. This is the first study to show that neonatal propofol-induced neurotoxicity is associated, at least in part, with changes in axonal transport of neurotrophic factors (BDNF) and altered neuronal connectivity. Studies of anaesthetic-mediated neurotoxicity in neonates has focused largely on apoptosis.
1e4,6,8e17,73e75 While it is logical to surmise that neuronal loss during development should result in cognitive deficits, there have been animal studies challenging this notion. 5, 18, 19 Anaesthetic exposure in neonates can induce cognitive dysfunction without neuronal apoptosis, and apoptosis can occur without resultant impairments in learning and memory. 5, 18, 20 In fact, hypercarbia-induced apoptosis in neonatal rodents actually improves cognitive function later in life. 18 While there is no doubt that anaesthesia induces neuroapoptosis beyond normal development, there is the possibility that other mechanisms contribute to the observed cognitive deficits with early anaesthetic exposure. Synaptogenesis and neuronal circuit formation during development determines later cognitive function. 54, 57, 58, 66 Formation of neuronal networks requires appropriate dendritic and axonal form/function. 23,25,48e50,65,76 Either isoflurane or propofol exposure of neonatal neurones results in dendritic Therefore, protecting neurones against anaesthetic-mediated neurotoxicity, by balancing overall Rho GTPase signalling, might be achieved through either RhoA inhibition (as seen herein) or Rac1/Cdc42 activation. 23, 88 The importance of properly balanced Rho GTPase activity to protect against anaesthetic-mediated neurotoxicity is revealed in a previous study from our group showing that the use of TAT-Pep5 before isoflurane exposure did not prevent cognitive dysfunction. 21 TAT-Pep5 inhibits RhoA activation by preventing p75 NTR -induced displacement of RhoA from RhoGDIs (Rho GDP-dissociation inhibitors); this results in a small pool of RhoA that cannot be activated. 89 That TAT-Pep5 only prevents activation of a small fraction of the total RhoA may explain why it does not prevent isoflurane-induced cognitive dysfunction in our previous study. 21 By contrast, TAT-C3 inhibits RhoA activation through ADP ribosylation of RhoA-GDP; this mechanism targets a larger fraction of RhoA, which may account for its ability to prevent propofolmediated cognitive deficits. A challenge in better understanding how propofol alters Rho GTPase activity is the promiscuity between RhoA, Rac1, and Cdc42 and the multiple upstream receptors; signalling is not limited to TrkB and p75 NTR . Other receptors that influence Rho GTPases include plexin, glutamate, GABA A , notch, and integrins. 90 There are many intermediary molecules that influence Rho GTPase activation; these include DISC1 and Cdk5. 90 After Rho GTPases are activated, the effects on actin dynamics are executed through many effector proteins, including cofilin, CRMP-2, and myosin-II. 23, 25 Collectively, the number of receptors that converge upon Rho GTPase signalling, along with the diversity of downstream effector proteins that regulate actin dynamics, makes Rho GTPase signalling complex. While there are still gaps in knowledge, our results are an initial and important step in better understanding of how propofol alters Rho GTPase signalling and influences neuronal development. Collectively, our findings advance our understanding of propofol-mediated neurotoxicity, describe a novel mechanism, set the stage for further investigations, and identify potential therapeutic targets. The observation that propofol alters retrograde axonal transport of BDNF is particularly noteworthy as we are the first to describe this pathological phenotype in neurones exposed to propofol. Deficits in retrograde axonal transport of trophic factor have been linked to cognitive impairment in many disorders such as Down's syndrome, Alzheimer's disease, and Huntington's disease. 78,91e97 The causes of axonal transport deficits in these neurological disorders are multifaceted, affecting several components of the axonal transport machinery. 30,78,96,98e102 Normal retrograde axonal transport of neurotrophins requires binding to surface receptors (i.e. TrkA, TrkB), endocytosis, recruitment of effector proteins and motor proteins, and access to axonal microtubules for guided transport. 30,44,102e104 Amongst the recruited signalling endosome effector proteins are Rho GTPases (RhoA, Rac1/Cdc42).
30,102
Rho GTPase and actin regulation are important for competent retrograde axonal transport. 30, 102 Given that propofol activates RhoA to alter actin regulation, it is not surprising that there is impaired transport of BDNF, and that these impairments are improved with RhoA inhibition and balanced Rho GTPase signalling; these findings are consistent with previous work.
11e13 ,30,102 Previously, we have shown that isoflurane induces neurotoxicity by preventing conversion of proBDNF to mBDNF, which results in preferential p75 NTR signalling.
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Increased p75 NTR signalling leads to increased RhoA activation and actin dysregulation, and actin dysregulation at the growth cone impairs retrograde axonal transport of neurotrophins. 30 Our findings are a logical extension of our previous findings that propofol causes increased proBDNF induced p75 NTR signalling, RhoA activation, actin dysregulation, and impaired axonal transport of neurotrophins. While we investigated the transport of exogenous QD-BDNF, it is likely that endogenous mBDNF transport is impaired as well based on the suggestion that the transport defect is at the level of endocytosis and signalling endosome formation, factors influenced by actin dynamics. 30 A more thorough investigation is needed to better understand how propofol impairs endocytosis and formation of signalling endosome. The impact of propofol on other axonal transport components (i.e. motor proteins and microtubules), if any, will also be addressed in future studies. Our in vitro findings that propofol causes RhoA-dependent loss of dendritic spines, growth cone collapse, and impaired retrograde axonal transport of BDNF led to experiments to determine if similar effects occur in vivo. Our data suggest that both dendritic and axonal components of neuronal development in the hippocampus are negatively impacted by neonatal exposure to propofol, and that these changes are associated with impaired learning and memory. Moreover, propofolassociated developmental defects in vivo are also caused by RhoA activation as evidenced by the observation that administration of a RhoA inhibitor before propofol exposure prevented neurotoxicity.
Learning and memory are largely dependent on neuronal networks within the hippocampus. 57 ,105e107 A region of particular importance is the IMF bundle, which arises from axons of dentate gyrus granule cells and synapse onto CA3 neurone apical dendrites. 55, 57, 108 Formation and pruning of the infrapyramidal bundle during development is important for later cognition. 53, 66, 109 Axonal pathfinding from the dentate gyrus to the CA3 region requires properly coordinated growth cone motility, along with normal retrograde axonal transport of neurotrophins. 23,25,45e47,58,62 Given that propofol causes growth cone collapse and impaired retrograde axonal transport in vitro, it is mechanistically consistent that infrapyramidal bundle area is decreased 28 days after propofol exposure. Additionally, infrapyramidal synapses with CA3 apical dendrites provide trophic support and encourage dendritic arborisation. 65, 110 As such, loss of infrapyramidal innervation to the CA3 region might contribute to reduced CA3 apical dendrite length and branching in mice exposed to propofol. Evidence that propofol decreases infrapyramidal axonal projections and impairs apical dendritic arborisation was supported by our findings that mice exposed to propofol exhibited loss of hippocampal synapses and presynaptic vesicles. Taken together, we believe that propofol-induced RhoA activation causes an imbalance in actin dynamics, resulting in altered infrapyramidal pathfinding to the CA3 region, blunted trophic support, decreased dendritic arborisation, and deficits in learning and memory. It is still unclear if defective infrapyramidal pathfinding is the only mechanism for decreased hippocampal synapse number and dendritic arborisation. It is possible that increased RhoA activation also acts directly at dendrites to cause dysregulation of actin and loss of dendritic arborisation that are related to synaptic activity and contribute to learning and memory. 111, 112 Further investigation is needed to better understand why other anaesthetics, such as ketamine, affect the infrapyramidal bundle differently than propofol; for example, ketamine exposure of neonatal rodents results in decreased infrapyramidal pruning. 113 Propofol acts primarily through gaminobutyric acid agonism, while ketamine acts through Nmethyl-D-aspartate receptor antagonism. There is evidence for a complex interplay between dimethylnitrosamine receptor activity and Rho GTPase activation. 114, 115 It is plausible that ketamine alters Rho GTPase signalling to favour actin polymerisation, leading to decreased pruning. Propofol leads to actin collapse, which might account for the loss of infrapyramidal bundles observed. These differences between propofol and ketamine need to be explored in future studies. It is likely that altered pruning (either too much or too little) alters synaptic connections that results in cognitive deficits. Despite the logical mechanistic connection between our in vitro, in vivo, and behavioural data, there remains the concern that neurones might mature and behave differently in a culture dish compared with their in vivo environment. There are few published data that compare how neurones mature in vitro and in vivo in the current toxicity model. However, other studies have used developing neurones of similar in vitro and in vivo age to show that the mechanisms for hippocampal development are similar in both environments. 116 Despite the confidence that our in vitro and in vivo findings are mechanistically linked, future studies will aim to confirm that exposing neonatal mice to propofol causes growth cone collapse and impairs axonal transport of neurotrophins in vivo.
In conclusion, our findings show that propofol exposure of neonatal neurones results in RhoA activation, growth cone collapse, impaired axonal transport of BDNF, altered hippocampal circuitry, and cognitive deficits. We are the first to propose altered neuronal pathfinding and connectivity as a mechanism for propofol-mediated neurotoxicity. Future research will address the following questions: (1) is the neurotoxicity seen with other anaesthetic; (2) are other Rho GTPases affected; (3) what are the contributing upstream and downstream signalling pathways from RhoA; and (4) are other components of axonal transport impaired? These studies could identify important therapeutic targets should anaesthetic-mediated neurotoxicity prove relevant in humans.
